Channing Paller

Johns Hopkins University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Pedro Barata

Associate Professor of Medicine

University Hospitals Seidman Cancer Center

UNITED STATES

View details

Scott Tagawa

Weill Cornell Medicine

UNITED STATES

View details

Gerhardt Attard

UNITED KINGDOM

View details

Sushant Kachhap

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Carolyn Ee

University of Western Sydney

AUSTRALIA

View details

Otis Brawley

Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Catherine Marshall

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Wei Chen

Professor

Wayne State University

UNITED STATES

View details

Maha Hussain

UNITED STATES

View details

Heather H. Cheng

University of Washington

UNITED STATES

View details

Janae Sweeney

Assistant Professor

University of South Carolina

UNITED STATES

View details

Scott W. Keith

UNITED STATES

View details

Russell Z. Szmulewitz

University of Chicago

UNITED STATES

View details

Kevin Kelly

Thomas Jefferson University

UNITED STATES

View details

Catherine Tangen

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Channing Paller

Research Interests

Explore related searches

Contact this professor

Articles (22)

Automated Extraction of Imaging and Pathology Data From Diverse Prostate Cancer Electronic Records

Integrating Botanicals into Oncology Care: Consideration of FDA Regulation of Botanical Products and Botanical Clinical Trials

Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

Phytonutrients and outcomes following breast cancer

Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Race-related Differences in Sipuleucel-T Response Among Men with Metastatic Castrate-Resistant Prostate Cancer

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness

Pan-Cancer Interrogation of MUTYH Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors

Therapeutic Approaches to Targeting Androgen Receptor Splice Variants

Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board

Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer

Analytical Validation of SOD2 Genotyping

Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)

Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis

On the Black–White Disparity in Prostate Cancer Mortality

The Realities of Prostate Cancer Screening, Treatment, and Race

Payer Coverage of Integrative Medicine Interventions for Symptom Control in Patients With Cancer

177Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Val16A SOD2 Polymorphism Promotes Epithelial–Mesenchymal Transition Antagonized by Muscadine Grape Skin Extract in Prostate Cancer Cells

Collaborators (15)

Pedro Barata

Scott Tagawa

Gerhardt Attard

Sushant Kachhap

Carolyn Ee

Otis Brawley

Catherine Marshall

Wei Chen

Maha Hussain

Heather H. Cheng

Janae Sweeney

Scott W. Keith

Russell Z. Szmulewitz

Kevin Kelly

Catherine Tangen

Make your next move.